Search by Drug Name or NDC
NDC 00310-4505-25 IMJUDO 25 mg/1.25mL Details
IMJUDO 25 mg/1.25mL
IMJUDO is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is TREMELIMUMAB.
Product Information
| NDC | 00310-4505 |
|---|---|
| Product ID | 0310-4505_4c293d27-b307-4b99-8ab0-904cf3d0353b |
| Associated GPIs | |
| GCN Sequence Number | 083970 |
| GCN Sequence Number Description | tremelimumab-actl VIAL 25 MG/1.25 INTRAVEN |
| HIC3 | V3J |
| HIC3 Description | CYTOTOXIC T-LYMPHOCYTE ANTIGEN(CTLA-4)RMC ANTIBODY |
| GCN | 53047 |
| HICL Sequence Number | 048415 |
| HICL Sequence Number Description | TREMELIMUMAB-ACTL |
| Brand/Generic | Brand |
| Proprietary Name | IMJUDO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tremelimumab |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1.25mL |
| Substance Name | TREMELIMUMAB |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761289 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00310-4505-25 (00310450525)
| NDC Package Code | 0310-4505-25 |
|---|---|
| Billing NDC | 00310450525 |
| Package | 1 VIAL in 1 CARTON (0310-4505-25) / 1.25 mL in 1 VIAL |
| Marketing Start Date | 2022-10-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |